Literature DB >> 9859753

Precursors to pulmonary neoplasia.

T V Colby1, I I Wistuba, A Gazdar.   

Abstract

Squamous dysplasia in the bronchi has been long recognized as a precursor of lung carcinoma, particularly squamous carcinoma. Atypical adenomatous hyperplasia (AAH) has been recently implicated as a precursor to adenocarcinoma. Bronchiolar neuroendocrine cell hyperplasia has also been suggested as a precursor to some pulmonary carcinoid tumors. The atypical adenomatous hyperplasia-adenocarcinoma sequence has been likened to the adenoma-carcinoma sequence in the large intestine. AAH is commonly multifocal, and may explain multicentricity that is observed with some adenocarcinomas. AAH has been shown to have immunohistochemical, morphometric, flow cytometric and genetic abnormalities overlapping with adenocarcinoma. Bronchiolar neuroendocrine cell hyperplasia (carcinoid tumorlets) is classically associated with inflammatory lesions in the airways, but may also be multifocal and bilateral. In the latter setting, lesions may attain a size greater than 0.5 cm and be (arbitrarily) classified as carcinoid tumors.

Entities:  

Mesh:

Year:  1998        PMID: 9859753     DOI: 10.1097/00125480-199807000-00001

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  20 in total

1.  Bronchiolar columnar cell dysplasia--genetic analysis of a novel preneoplastic lesion of peripheral lung.

Authors:  Reinhard Ullmann; Massimo Bongiovanni; Iris Halbwedl; Susanna Petzmann; Margit Gogg-Kammerer; Anna Sapino; Mauro Papotti; Gianni Bussolati; Helmut H Popper
Journal:  Virchows Arch       Date:  2003-04-09       Impact factor: 4.064

2.  CT findings of atypical adenomatous hyperplasia in the lung.

Authors:  Chang Min Park; Jin Mo Goo; Hyun Ju Lee; Chang Hyun Lee; Hyo-Cheol Kim; Doo Hyun Chung; Jung-Gi Im
Journal:  Korean J Radiol       Date:  2006 Apr-Jun       Impact factor: 3.500

Review 3.  Pulmonary preinvasive neoplasia.

Authors:  K M Kerr
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

4.  Fluorescent metal nanoshell probe to detect single miRNA in lung cancer cell.

Authors:  Jian Zhang; Yi Fu; Yuping Mei; Feng Jiang; Joseph R Lakowicz
Journal:  Anal Chem       Date:  2010-06-01       Impact factor: 6.986

5.  Molecular profiling of premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis.

Authors:  Aik T Ooi; Adam C Gower; Kelvin X Zhang; Jessica L Vick; Longsheng Hong; Brian Nagao; W Dean Wallace; David A Elashoff; Tonya C Walser; Steven M Dubinett; Matteo Pellegrini; Marc E Lenburg; Avrum Spira; Brigitte N Gomperts
Journal:  Cancer Prev Res (Phila)       Date:  2014-03-11

6.  Preneoplasia of lung cancer.

Authors:  Adi F Gazdar; Elisabeth Brambilla
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

7.  Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung.

Authors:  K Takamochi; T Ogura; K Suzuki; H Kawasaki; Y Kurashima; T Yokose; A Ochiai; K Nagai; Y Nishiwaki; H Esumi
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

8.  Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers.

Authors:  Lei Yu; Nevins W Todd; Lingxiao Xing; Ying Xie; Howard Zhang; Zhenqiu Liu; Hongbin Fang; Jian Zhang; Ruth L Katz; Feng Jiang
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

Review 9.  Ten years of disease-free survival between two diagnoses of small-cell lung cancer: a case report and a literature review.

Authors:  M Al-Ajam; A Seymour; M Mooty; A Leaf
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

10.  Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer.

Authors:  Carmen Behrens; Heather Y Lin; J Jack Lee; Maria Gabriela Raso; Waun Ki Hong; Ignacio I Wistuba; Reuben Lotan
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.